Tags: shortage | flu | vaccine | Tamiflu | severe | influenza

Shortages of Flu Vaccine Reported

Thursday, 10 Jan 2013 12:09 PM


This year's early and potentially severe flu season has created shortages of the children's formulation of the leading treatment and most forms of the top-selling U.S. vaccine, according to their manufacturers.
Roche Holding AG told Reuters late on Wednesday that it had a shortage of the liquid formulation of Tamiflu, which is used mainly to slow down or stop the symptoms of the flu in children already infected with the virus.
Roche said the company had informed wholesalers and distributors in recent weeks that they would face temporary delays in shipments. Pharmacists can create a substitute oral formulation by dissolving Tamiflu capsules into a sweet liquid, according to Tara Iannuccillo, spokeswoman for Roche's Genentech unit, which makes Tamiflu.
Sanofi SA, the largest flu vaccine provider in the United States, said on Thursday that it had sold out of four of its six formulations of its Fluzone seasonal flu vaccine due to the unanticipated late-season demand for vaccines.





© HealthDay

 
1Like our page
2Share
Health-News
Pharmaceutical manufacturers say the severe flu season has caused shortages of flu vaccine and Tamiflu, the drug used to slow the virus in people who are stricken with influenza.
shortage,flu,vaccine,Tamiflu,severe,influenza
157
2013-09-10
Thursday, 10 Jan 2013 12:09 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved